The genetic sonogram - A method of risk assessment for Down syndrome in the second trimester

被引:139
作者
Bromley, B
Lieberman, E
Shipp, TD
Benacerraf, BR
机构
[1] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
aneuploidy risk assessment; fetal Down syndrome markers; genetic sonogram; prenatal sonography; trisomy; 21;
D O I
10.7863/jum.2002.21.10.1087
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
To determine the risk of Down syndrome in fetuses with sonographic markers using the Bayes theorem and likelihood ratios. Methods. We prospectively evaluated the midtrimester sonographic features of fetuses with Down syndrome and compared them with euploid fetuses. Patients were referred for an increased risk of aneuploidy and evaluated for the presence of structural defects, a nuchal fold, short long bones, pyelectasis, an echogenic intracardiac focus, and hyperechoic bowel. All fetuses underwent amniocentesis at the time of sonographic assessment. The sensitivity, specificity, and likelihood ratios for markers were calculated both as nonisolated and isolated findings. Results. There were 164 fetuses with Down syndrome and 656 euploid fetuses. The presence of any marker resulted in sensitivity for the detection of Down syndrome of 80.5% with a false-positive rate of 12.4%. The absence of any markers conferred a likelihood ratio of 0.2, decreasing the risk of Down syndrome by 80%. As an isolated marker, the nuchal fold had an "infinite" likelihood ratio for Down syndrome; a short humerus had a likelihood ratio of 5.8, whereas structural anomalies had a likelihood ratio of 3.3. Other isolated markers had low likelihood ratios because of the higher prevalence in the unaffected population. The likelihood ratios for the presence of 1, 2, and 3 of any of the markers were 1.9, 6.2, and 80, respectively. Conclusions. Although an isolated marker with a low likelihood ratio may not increase a patient's risk of Down syndrome, the presence of such a marker precludes reducing the risk of aneuploidy. Clusters of markers appear to confer a higher risk.
引用
收藏
页码:1087 / 1096
页数:10
相关论文
共 42 条
[21]  
Cuckle H, 2000, BRIT MED J, V321, P763
[22]   Trisomy 21: 91% detection rate using second-trimester ultrasound markers [J].
Devore, GR .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2000, 16 (02) :133-141
[23]  
DONNENFELD AE, 1994, OBSTET GYNECOL, V84, P844
[24]  
Filly RA, 2000, J ULTRAS MED, V19, P1
[25]  
Hobbins JC, 2001, J ULTRAS MED, V20, P569
[26]  
INGELFINGER JA, 1983, BIOSTATISTICS CLIN M, P29
[27]   Changing trends in patient decisions concerning genetic amniocentesis [J].
Kocun, CC ;
Harrigan, JT ;
Canterino, JC ;
Feld, SM ;
Fernandez, CO .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (05) :1018-1020
[28]  
NADEL AS, 1995, J ULTRAS MED, V14, P297
[29]  
NYBERG DA, 1990, OBSTET GYNECOL, V76, P370
[30]   Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases [J].
Nyberg, DA ;
Luthy, DA ;
Resta, RG ;
Nyberg, BC ;
Williams, MA .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 12 (01) :8-14